Internal Medicine, Gastroenterology · Yonkers, NY
NPI
1770571135
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1086 N Broadway Ste 50
Yonkers, NY, 10701
Phone (914) 375-6400
Groups this clinician bills Medicare through
Medicare paid, 2024
$131K
1,455 services
Medicare patients, 2024
475
Average age 72
Drug cost, 2024
$3.1M
6,757 prescriptions
Company payments, 2025
$252
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose L Lantin was code 99213 (office e&m - established), 793 times for 336 patients. In total Jose L Lantin billed 1,455 services in 28 codes, and Medicare paid $131K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 793 | 336 | $72.41 | $57K |
| 99203 Office E&M - New | Office | 142 | 142 | $87.23 | $12K |
| 43239 Upper GI Endoscopy | Facility | 121 | 117 | $109.08 | $13K |
| 45380 Lower GI Endoscopy - Other | Facility | 83 | 81 | $130.19 | $11K |
| 99231 Hospital E&M - Subsequent | Facility | 73 | 26 | $44.12 | $3,221 |
| 45385 Colonoscopy - Lesion Removal | Facility | 51 | 51 | $173.22 | $8,834 |
| 45378 Lower GI Endoscopy - Other | Facility | 42 | 42 | $158.60 | $6,661 |
| 99222 Hospital E&M - Initial | Facility | 28 | 26 | $112.25 | $3,143 |
| 76981 Ultrasound - Nonspecific | Office | 25 | 25 | $92.82 | $2,321 |
| 99214 Office E&M - Established | Office | 18 | 18 | $112.37 | $2,023 |
| 91200 Standard X-ray | Office | 13 | 13 | $28.44 | $370 |
| 45382 Lower GI Endoscopy - Other | Facility | 13 | 13 | $229.51 | $2,984 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 11 | 11 | $13.21 | $145 |
By year: 2022 $191K for 2,459 services; 2023 $149K for 1,714 services; 2024 $131K for 1,455 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86328 Immunoassay | 29 | 29 | $44.37 | $1,287 |
| 86769 Immunoassay | 29 | 29 | $41.29 | $1,197 |
Medicare prescription drug claims, 2024
In 2024, the drug Jose L Lantin prescribed most often to Medicare patients was Omeprazole, with 1,781 prescriptions and refills. In total Jose L Lantin wrote 6,757 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 1,781 | 2,164 | 440 | $12K |
| Zenpep Lipase/Protease/Amylase | 864 | 960 | 219 | $1.3M |
| Linzess Linaclotide | 560 | 628 | 133 | $322K |
| Famotidine Generic | 418 | 581 | 131 | $2,945 |
| Pantoprazole Sodium Generic | 389 | 534 | 106 | $2,077 |
| Metronidazole Generic | 387 | 387 | 313 | $4,156 |
| Lansoprazole Generic | 131 | 160 | 34 | $1,972 |
| Sucralfate Generic | 110 | 123 | 56 | $28K |
| Creon Lipase/Protease/Amylase | 103 | 116 | 30 | $119K |
| Metoclopramide Hcl Generic | 101 | 105 | 91 | $553 |
| Hydrocortisone Generic | 93 | 97 | 52 | $1,635 |
| Lubiprostone Generic | 89 | 115 | 29 | $14K |
| Fluticasone Propionate Generic | 88 | 146 | 39 | $935 |
| Ondansetron Hcl Generic | 85 | 85 | 39 | $989 |
| Rosuvastatin Calcium Generic | 82 | 148 | 25 | $700 |
Brand drugs: - claims; generic drugs: 4,755 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose L Lantin $252 ($252 in general payments such as food, travel and fees) from 2 companies. The largest payer was Xeris Pharmaceuticals, Inc. with $135.
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $135 |
| Ardelyx, Inc. ARDX | 1 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.